Pre-messenger RNA with partial complementarity to the U7 antisense sequence

The term "Other pre-mRNAs with partial complementarity to the U7 antisense sequence" refers to a broad class of unintended RNA transcripts that may interact with therapeutic antisense sequences delivered via the U7 small nuclear RNA (snRNA) system. The U7 snRNA is a specialized component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which naturally functions in the 3' end processing of histone pre-mRNAs (Schümperli & Pillai, 2004). In gene therapy applications, the U7 snRNA is often engineered to carry antisense sequences designed to bind to specific splice sites, thereby inducing exon skipping or inclusion for diseases like Duchenne Muscular Dystrophy (Goyenvalle et al., 2004). However, the specificity of these antisense sequences is not absolute, and partial complementarity to non-target pre-mRNAs can lead to unintended splicing alterations or transcript degradation. These off-target interactions represent a significant safety concern in the development of U7-based therapies, as they can disrupt the expression of essential genes and lead to cellular toxicity (Vulin et al., 2012). Consequently, rigorous bioinformatic screening and experimental validation are required to identify and minimize these "other" pre-mRNA interactions during drug development.

Other names

Off-target pre-mRNAsU7 snRNA off-targetsUnintended antisense targetsU7-mediated off-target transcripts

Antisense binding to non-target pre-mRNA sequences leading to steric hindrance of splicing factors, recruitment of the U7 snRNP complex to unintended sites, or degradation of the transcript.